Drugs Made In America Acquisition (DMII) Change in Account Payables (2025)

Drugs Made In America Acquisition (DMII) reported Change in Account Payables of $94767.0 for Q4 2025.

Drugs Made In America Acquisition (DMII) Change in Account Payables (2025) Analysis & Trends

Drugs Made In America Acquisition (DMII) has 1 years of Change in Account Payables data on file, last reported at $94767.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - -
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - -
3 Berto Acquisition 311.56 Mn 311.56 Mn - -1,876.00
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - -
5 Centurion Acquisition 310.21 Mn 310.21 Mn - -
6 WEN Acquisition 309.15 Mn 309.15 Mn - -
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - -6.67 Mn
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - 4,745.00
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - -
10 Drugs Made In America Acquisition 129.34 Mn 129.34 Mn - 94,767.00

Historic Data

Download Data
DateValue
Dec 31, 2025 94,767.00
Dec 31, 2025 94,767.00